Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2) (C-Term) Peptide
Quick Overview for Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2) (C-Term) Peptide (ABIN976179)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- FWSDRRNPHE VKPAYATRYA ITVWYFDAKE RAAARDKYQL ASGQKGVQVP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Egln2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
-
Background
-
HIF-prolyl hydroxylase 1, might be involved in might play a role in hypoxic preconditioning.
Alias Symbols: MGC93662, MGC93666, PHD-1, PHD1, HPH-1, HPH-3, HIF-PH1
Protein Size: 415 -
Molecular Weight
- 45 kDa
-
Gene ID
- 308457
-
NCBI Accession
- NM_001004083, NP_001004083
-
UniProt
- Q6AYU4
Target
-